Mechanism of Exosomal LncRNA PART1 in Esophageal Cancer Angiogenesis by Targeting miR-302a-3p/CDC25A Axis. 2023

Naixin Ding, and Xue Song, and Hongliang Yu, and Jie Wang, and Lei Huang, and Yiqin Zhou, and Xia He
Department of Radiotherapy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.

LncRNA PART1 has been confirmed related to multiple cancer bioactivities mediated with vascular endothelial growth factor signaling. Nevertheless, the role of LncRNA PART1 in esophageal cancer induced angiogenesis remains unclear. The present work focused on assessing LncRNA PART1 effects on esophageal cancer-induced angiogenesis and exploring possible mechanisms. Western blot and immunofluorescence were conducted for identifying EC9706 exosomes. MiR-302a-3p and LncRNA PART1 levels were assessed by real-time quantitative polymerase chain reaction. Cell Counting Kit-8, EdU, wound healing, transwell, and tubule information were adopted for detecting human umbilical vein endothelial cell viability, proliferation, migration, invasion, and tubule information, respectively. Starbase software and dual-luciferase reporter were conducted for predicting and judging the expression interrelation of LncRNA PART1 and its potential target-miR-302a-3p. The same methods were carried out for verifying the inhibiting influences of miR-302a-3p upregulation and its potential target-cell division cycle 25 A. LncRNA PART1 levels were upregulated and related to the overall survival of patients in esophageal cancer. EC9706-Exos accelerated human umbilical vein endothelial cell proliferation, migration, invasion, and tubule formation via LncRNA PART1. LncRNA PART1 served as a sponge of miR-302a-3p, then miR-302a-3p targeted cell division cycle 25 A, and EC9706-Exos accelerated human umbilical vein endothelial cell angiogenesis via LncRNA PART1/ miR-302a-3p/cell division cycle 25 A axis. EC9706-Exos accelerates human umbilical vein endothelial cell angiogenesis via LncRNA PART1/miR-302a-3p/ cell division cycle 25 A axis, indicating EC9706-Exos may act as a promoter of angiogenesis. Our research will contribute to clarify the mechanism of tumor angiogenesis.

UI MeSH Term Description Entries
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D042461 Vascular Endothelial Growth Factor A The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as "tumor angiogenesis factor" and "vascular permeability factor". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced. Vascular Endothelial Growth Factor,Vascular Endothelial Growth Factor-A,GD-VEGF,Glioma-Derived Vascular Endothelial Cell Growth Factor,VEGF,VEGF-A,Vascular Permeability Factor,Vasculotropin,Glioma Derived Vascular Endothelial Cell Growth Factor,Permeability Factor, Vascular
D062085 RNA, Long Noncoding A class of untranslated RNA molecules that are typically greater than 200 nucleotides in length and do not code for proteins. Members of this class have been found to play roles in transcriptional regulation, post-transcriptional processing, CHROMATIN REMODELING, and in the epigenetic control of chromatin. LincRNA,RNA, Long Untranslated,LINC RNA,LincRNAs,Long Intergenic Non-Protein Coding RNA,Long Non-Coding RNA,Long Non-Protein-Coding RNA,Long Noncoding RNA,Long ncRNA,Long ncRNAs,RNA, Long Non-Translated,lncRNA,Long Intergenic Non Protein Coding RNA,Long Non Coding RNA,Long Non Protein Coding RNA,Long Non-Translated RNA,Long Untranslated RNA,Non-Coding RNA, Long,Non-Protein-Coding RNA, Long,Non-Translated RNA, Long,Noncoding RNA, Long,RNA, Long Non Translated,RNA, Long Non-Coding,RNA, Long Non-Protein-Coding,Untranslated RNA, Long,ncRNA, Long,ncRNAs, Long
D020687 cdc25 Phosphatases A subclass of dual specificity phosphatases that play a role in the progression of the CELL CYCLE. They dephosphorylate and activate CYCLIN-DEPENDENT KINASES. Cell Division Cycle 25B protein,Dual Specificity Phosphatase Cdc25A,Dual Specificity Phosphatase Cdc25B,Dual Specificity Phosphatase Cdc25C,M-Phase Inducer Phosphatase 1,M-Phase Inducer Phosphatase 2,M-Phase Inducer Phosphatase 3,cdc25 Phosphatase,cdc25A Phosphatase,cdc25B Phosphatase,cdc25C Phosphatase,M Phase Inducer Phosphatase 1,M Phase Inducer Phosphatase 2,M Phase Inducer Phosphatase 3,Phosphatase, cdc25,Phosphatase, cdc25A,Phosphatase, cdc25B,Phosphatase, cdc25C,Phosphatases, cdc25
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Naixin Ding, and Xue Song, and Hongliang Yu, and Jie Wang, and Lei Huang, and Yiqin Zhou, and Xia He
May 2024, Korean circulation journal,
Naixin Ding, and Xue Song, and Hongliang Yu, and Jie Wang, and Lei Huang, and Yiqin Zhou, and Xia He
March 2019, Journal of cellular biochemistry,
Naixin Ding, and Xue Song, and Hongliang Yu, and Jie Wang, and Lei Huang, and Yiqin Zhou, and Xia He
January 2022, Cancer management and research,
Naixin Ding, and Xue Song, and Hongliang Yu, and Jie Wang, and Lei Huang, and Yiqin Zhou, and Xia He
January 2022, Genetics research,
Naixin Ding, and Xue Song, and Hongliang Yu, and Jie Wang, and Lei Huang, and Yiqin Zhou, and Xia He
December 2024, Cancer biology & therapy,
Naixin Ding, and Xue Song, and Hongliang Yu, and Jie Wang, and Lei Huang, and Yiqin Zhou, and Xia He
May 2019, Neoplasma,
Naixin Ding, and Xue Song, and Hongliang Yu, and Jie Wang, and Lei Huang, and Yiqin Zhou, and Xia He
January 2023, The Kaohsiung journal of medical sciences,
Naixin Ding, and Xue Song, and Hongliang Yu, and Jie Wang, and Lei Huang, and Yiqin Zhou, and Xia He
June 2021, DNA and cell biology,
Naixin Ding, and Xue Song, and Hongliang Yu, and Jie Wang, and Lei Huang, and Yiqin Zhou, and Xia He
January 2020, Cancer management and research,
Naixin Ding, and Xue Song, and Hongliang Yu, and Jie Wang, and Lei Huang, and Yiqin Zhou, and Xia He
February 2024, Journal of chemotherapy (Florence, Italy),
Copied contents to your clipboard!